New adaptive clinical trial offers new hope for progressive multiple sclerosis
The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
Two Griffith University research projects have been successful in gaining grants from the Medical Research Future Fund (MRFF) worth a combined $2.7 million.
Vanessa Lee is celebrating following her graduation this week from Griffith University School of Medicine, as its first Aboriginal and Torres Strait Islander Public Health PhD graduate.
The value of research for clinical practice was the focus of discussion as part of the 10 year anniversary celebration of Griffith’s School of Medicine.
Advances in the treatment of Multiple Sclerosis have been good news for patients, but side effects and risks mean that an active management strategy and constant monitoring are essential.
The Australian Medical Council (AMC) has reaccredited the School of Medicine’s medical programs for a further term ending 31 March 2021.
The Hon. Kevin Rudd MP visits Griffith to discuss organ donation.
Griffith University Dean of Medicine Professor Simon Broadley has described a breakthrough in multiple sclerosis research as ___the biggest step...
A medical centre in rural Ghana owes a large part of its construction to the determined efforts of Griffith University...
A medical centre in rural Ghana owes a large part of its construction to the determined efforts of Griffith University...